Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple
Jens Ingvarsson1, Viktor Grut1, Martin Biström1
1Department of Clinical Sciences, Neurosciences Umeå University Umeå Sweden.
Objective:
Several factors have been associated with altered risk of developing multiple sclerosis (MS). Epstein-Barr virus (EBV) is the critical risk factor for MS, but recent studies indicate that human herpesvirus 6A (HHV-6A) and cytomegalovirus (CMV) are involved in MS aetiopathogenesis. We recently reported an association between rubella virus (RV) envelope protein 1 (E1) seropositivity and the risk of developing MS. Here, we aimed to further explore this association.
Methods:
Bio-banked blood samples collected before the onset of MS from 981 cases and 1278 matched controls were analysed for antibodies against RV envelope proteins 1 and 2 (E2), and serum-neurofilament light chain (S-NfL), a marker for axonal injury. The association between RV and MS was analysed with conditional logistic regression, calculating odds ratios (OR) with 95% confidence intervals (CI).
Results:
Rubella E1 seropositivity was significantly associated with a higher risk of MS development, even when adjusting for EBV, CMV and HHV-6A serostatus (OR = 1.67, 95% CI 1.29-2.14, P < 0.001). We also observed an increase in seroreactivity against RV E1 before an increase in S-NfL in MS cases, indicating that increased RV E1 seroreactivity precedes axonal injury in the MS prodrome at group-level. There was no association between RV E2 serostatus and MS risk. The association between RV E1 serostatus and MS risk remained similar when the analysis was restricted to unvaccinated participants (OR = 1.78, 95% CI 1.07-2.98, P = 0.028).
Conclusions:
Our results support a broadening of the viral hypothesis in MS, arguing for further studies on the neurotropic RV in MS aetiology.
Insights
Rubella virus (RV) E1 antibodies are linked to increased multiple sclerosis (MS) risk, even after accounting for other viruses. This suggests RV may play a role in MS development, preceding axonal injury.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Multiple sclerosis (MS) risk is influenced by various factors, including Epstein-Barr virus (EBV), human herpesvirus 6A (HHV-6A), and cytomegalovirus (CMV).
- Previous research indicated a potential association between rubella virus (RV) envelope protein 1 (E1) seropositivity and MS risk.
Purpose of the Study:
- To investigate the association between rubella virus (RV) envelope protein 1 (E1) and envelope protein 2 (E2) seropositivity and the risk of developing multiple sclerosis (MS).
- To explore the temporal relationship between RV E1 seroreactivity and axonal injury markers in MS cases.
Main Methods:
- Analysis of pre-onset bio-banked blood samples from 981 MS cases and 1278 matched controls.
- Assays for antibodies against RV E1 and E2, and serum-neurofilament light chain (S-NfL).
- Conditional logistic regression used to analyze the association between RV serostatus and MS risk, adjusting for other viral infections.
Main Results:
- Rubella E1 seropositivity was significantly associated with an increased risk of MS (OR=1.67, P<0.001), independent of EBV, CMV, and HHV-6A status.
- Increased RV E1 seroreactivity was observed to precede elevations in S-NfL, suggesting it occurs before axonal injury in the MS prodrome.
- No association was found between RV E2 serostatus and MS risk.
Conclusions:
- The findings support the broadening of the viral hypothesis in multiple sclerosis etiology.
- Further research into the neurotropic potential of rubella virus in MS pathogenesis is warranted.
More Related Videos
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
08:03Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
Related Concept Videos
Multiple Sclerosis l: Introduction
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Arboviral Encephalitis
Encephalitis l: Introduction
Cytomegalovirus Disease